My Companies
Notification
Account
US FDA classified Aug 13-21 inspection of Caplin Steriles Gummidipoondi injectable/ophthalmic plant as OAI after 10 procedural observations; company says no material impact, plant continues supplies.
Caplin Point Gains INVIMA GMP Compliance Confirmation For Oncology Manufacturing Unit
Caplin Point Laboratories Receives FDA Form 483 With 10 Observations